Life
FDA Grants Leucovorin Approval for Rare Disorder Without Traditional Trial Data
The FDA's recent approval of Leucovorin for a rare disorder, lacking conventional trial data, prompts a reevaluation of drug evaluation protocols and potential impacts on infrastructure.
Editorial Staff 26 days ago